Replies to post #14081 on DNAprint Genomics (DNAG)

[ann441j]

Tampa Bay's Market is "Hot":

Today's News
Highlights of Economic and Business Growth in the Tampa Bay Region (Shorts)

TAMPA BAY, Fla., April 6 /PRNewswire/ -- Here are some shorts concerning
the economic and business growth in the Tampa Bay Region from the Tampa Bay
Partnership:

Tampa Bay's Office Market Is in High Demand
Tampa Bay's office market is "hot" and continues to outperform most others
in the U.S. Pinellas County took the top spot nationally in the ranking of
non-downtown office markets, and Tampa's downtown office market ranked No. 2
in the nation according to the Cushman & Wakefield Barometer, a projected
ranking of commercial real estate market performance over the next two years.
For more information, contact Sam Zein at 813-223-6300 or
[e-mail].

USF Entrepreneurship Program Ranked #1 in the Nation
The Life Sciences Entrepreneurship program at the University of South
Florida was named the number one specialty program in entrepreneurship in 2004
by the United States Association for Small Business and Entrepreneurship
(USASBE), which commended the program as a national model. The first place
award recognized USF's innovative and nationally benchmarked research,
education and training programs in life sciences entrepreneurship. For more
information, contact Michelle Carlyon at 813-974-9082 or visit
http://www.entrepreneurship.usf.edu.

Florida Tech Transfer Conference
The Florida Research Consortium and the Tampa Bay Technology Forum
announced they will be holding the first annual Florida Tech Transfer
Conference in St. Petersburg, Florida, May 17 - 18, 2004. The conference will
showcase emerging technologies and commercialization opportunities from the
state's leading research universities in the areas of information technology,
biotechnology and nanotechnology. For more information, visit
http://frc.accrisoft.com/techtransfer.

Moffitt Teams with DNAPrint(TM) to Predict Patient Response to
Chemotherapy
The H. Lee Moffitt Cancer Center & Research Institute announced that it
has formed a joint research program with the Sarasota-based DNAPrint(TM)
Genomics, Inc., to develop and implement new clinical tests for predicting
patient response to cancer chemotherapies. The collaboration will combine
Moffitt oncologists, research scientists, mathematicians and software
engineers with DNAPrint(TM) computer scientists, molecular biologists and
population geneticists. For more information, E-mail
[e-mail] or call [phone].

Ann